Adamczak, M.; Kurnatowska, I.; Naumnik, B.; Stompór, T.; Tylicki, L.; Krajewska, M.
Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology. Int. J. Mol. Sci. 2024, 25, 12941.
https://doi.org/10.3390/ijms252312941
AMA Style
Adamczak M, Kurnatowska I, Naumnik B, Stompór T, Tylicki L, Krajewska M.
Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology. International Journal of Molecular Sciences. 2024; 25(23):12941.
https://doi.org/10.3390/ijms252312941
Chicago/Turabian Style
Adamczak, Marcin, Ilona Kurnatowska, Beata Naumnik, Tomasz Stompór, Leszek Tylicki, and Magdalena Krajewska.
2024. "Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology" International Journal of Molecular Sciences 25, no. 23: 12941.
https://doi.org/10.3390/ijms252312941
APA Style
Adamczak, M., Kurnatowska, I., Naumnik, B., Stompór, T., Tylicki, L., & Krajewska, M.
(2024). Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology. International Journal of Molecular Sciences, 25(23), 12941.
https://doi.org/10.3390/ijms252312941
